- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glycosphingolipids and neuroinflammation in Parkinson’s disease ; volume:15 ; number:1 ; day:17 ; month:10 ; year:2020 ; pages:1-16 ; date:12.2020
Molecular neurodegeneration ; 15, Heft 1 (17.10.2020), 1-16, 12.2020
- Urheber
-
Belarbi, Karim
Cuvelier, Elodie
Bonte, Marie-Amandine
Desplanque, Mazarine
Gressier, Bernard
Devos, David
Chartier-Harlin, Marie-Christine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-020-00408-1
- URN
-
urn:nbn:de:101:1-2020120218484840413882
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Belarbi, Karim
- Cuvelier, Elodie
- Bonte, Marie-Amandine
- Desplanque, Mazarine
- Gressier, Bernard
- Devos, David
- Chartier-Harlin, Marie-Christine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neuroinflammation and protein pathology in Parkinson’s disease dementia
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Modeling Neuroinflammation in sporadic Parkinson ́s disease
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice
Neuroinflammation and protein pathology in Parkinson’s disease dementia
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Modeling Neuroinflammation in sporadic Parkinson ́s disease
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice
Neuroinflammation and protein pathology in Parkinson’s disease dementia
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Neuroinflammation in Parkinson’s disease – putative pathomechanisms and targets for disease-modification
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Modeling Neuroinflammation in sporadic Parkinson ́s disease
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson’s disease
NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models